Mylan Shares Tumble On Generic Drugs Collusion Probe

Jon Alternative Media, Blogosphere, Corruption, Government

Mylan’s second-highest-ranking executive, Rajiv Mailk, is the target of a civil investigation by dozens of states conducting in a widespread, multiyear probe into alleged price collusion by makers of generic drugs.
As Bloomberg reports, state attorneys general said they’re seeking to sue Rajiv Malik, Mylan’s president and executive director, as part of an expanded complaint against pharmaceutical companies from 45 states and the District of Columbia, according to a statement by Connecticut Attorney General George Jepsen.
Malik would be the first senior executive from a major drugmaker sued in the case.

This post was published at Zero Hedge on Oct 31, 2017.